Rakovina Therapeutics Inc. RKVTF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.59% | -53.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.19% | -16.77% | |||
| Operating Income | -6.19% | 16.77% | |||
| Income Before Tax | -2.21% | 10.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.21% | 10.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.21% | 10.07% | |||
| EBIT | -6.19% | 16.77% | |||
| EBITDA | -6.57% | 18.15% | |||
| EPS Basic | 7.43% | 13.88% | |||
| Normalized Basic EPS | 1.54% | 19.75% | |||
| EPS Diluted | 12.35% | 9.05% | |||
| Normalized Diluted EPS | 1.54% | 19.75% | |||
| Average Basic Shares Outstanding | 10.33% | 4.47% | |||
| Average Diluted Shares Outstanding | 10.33% | 4.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||